drug
(brimonidine tartrate + brinzolamide)
Marketedupdated 5mo agoby $NVS NOVARTIS AG
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying (brimonidine tartrate + brinzolamide)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 17, 2030
~3.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Oct 30, 2030formulationUS 90444844.1y
- Jun 17, 2030formulationUS 94212653.7y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that